Marker Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Marker Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Marker Therapeutics Inc
Rating: 1.22116675
Author: Trendlyne DVM scores

about

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...

1.41 -0.14 (-9.03%)

76.30% Fall from 52W High

287.8K

XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

24.2 / 100

Technically Bearish

24.7 / 100

1Yr Price target upside is 326%

2 analysts

Marker Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Marker Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...

76.30% Fall from 52W High

SWOT Analysis

Marker Therapeutics Inc Live Price Chart